# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-137599
Filing Date
2012-03-28
Accepted
2012-03-28 17:11:56
Documents
26
Period of Report
2011-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | d275067d10k.htm | 10-K | 1177716
2 | WARRANT NO. 2012-1 IN FAVOR OF LEGEND SECURITIES, INC. | d275067dex49.htm | EX-4.9 | 91214
3 | FIRST AMENDMENT TO CONTIGENT VALUE RIGHTS AGREEMENT | d275067dex102.htm | EX-10.2 | 27353
4 | SECOND OMNIBUS AMENDMENT TO SECURITIES PURCHASE AGREEMENT | d275067dex1037.htm | EX-10.37 | 12793
5 | LEASE BETWEEN GALENA BIOPHARMA, INC. AND LO 138, LLC | d275067dex1043.htm | EX-10.43 | 122911
6 | LEASE AGREEMENT, EFFECTIVE AS OF APRIL 30, 2009 | d275067dex1045.htm | EX-10.45 | 111137
7 | AMENDMENT NO. 1 TO LICENSE AGREEMENT, DATED JANUARY 13, 2012 | d275067dex1046.htm | EX-10.46 | 15280
8 | SEPARATION AND TRANSITION AGREEMENT | d275067dex1047.htm | EX-10.47 | 33996
9 | SUBSIDIARIES OF THE REGISTRANT | d275067dex211.htm | EX-21.1 | 3632
10 | CONSENT OF BDO USA, LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | d275067dex231.htm | EX-23.1 | 1778
11 | SARBANES-OXLEY ACT SECTION 302 CERTIFICATION OF MARK J. AHN | d275067dex311.htm | EX-31.1 | 9193
12 | SARBANES-OXLEY ACT SECTION 302 CERTIFICATION OF CAITLIN KONTULIS | d275067dex312.htm | EX-31.2 | 9272
13 | SARBANES-OXLEY ACT SECTION 906 CERTIFICATION OF MARK J. AHN AND CAITLIN KONTULIS | d275067dex321.htm | EX-32.1 | 3637
20 | GRAPHIC | g275067ex10_4346.jpg | GRAPHIC | 221702
21 | GRAPHIC | g275067ex10_4347.jpg | GRAPHIC | 257341
22 | GRAPHIC | g275067g17q90.jpg | GRAPHIC | 21139
23 | GRAPHIC | g275067g33o37.jpg | GRAPHIC | 22573
24 | GRAPHIC | g275067g35o58.jpg | GRAPHIC | 39421
25 | GRAPHIC | g275067g36l13.jpg | GRAPHIC | 10999
26 | GRAPHIC | g275067g72o39.jpg | GRAPHIC | 20318
| Complete submission text file | 0001193125-12-137599.txt |  | 5365049

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
14 | XBRL INSTANCE DOCUMENT | rxii-20111231.xml | EX-101.INS | 541781
15 | XBRL TAXONOMY EXTENSION SCHEMA | rxii-20111231.xsd | EX-101.SCH | 28880
16 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | rxii-20111231_cal.xml | EX-101.CAL | 44102
17 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | rxii-20111231_def.xml | EX-101.DEF | 38039
18 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | rxii-20111231_lab.xml | EX-101.LAB | 217962
19 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | rxii-20111231_pre.xml | EX-101.PRE | 129180

Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33958 | Film No.: 12721330
SIC: 2834 Pharmaceutical Preparations